BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21425331)

  • 1. GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo.
    Pi M; Wu Y; Quarles LD
    J Bone Miner Res; 2011 Jul; 26(7):1680-3. PubMed ID: 21425331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells.
    Pi M; Kapoor K; Ye R; Nishimoto SK; Smith JC; Baudry J; Quarles LD
    Endocrinology; 2016 May; 157(5):1866-80. PubMed ID: 27007074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants.
    Rueda P; Harley E; Lu Y; Stewart GD; Fabb S; Diepenhorst N; Cremers B; Rouillon MH; Wehrle I; Geant A; Lamarche G; Leach K; Charman WN; Christopoulos A; Summers RJ; Sexton PM; Langmead CJ
    PLoS One; 2016; 11(1):e0146846. PubMed ID: 26785252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPRC6A mediates the effects of L-arginine on insulin secretion in mouse pancreatic islets.
    Pi M; Wu Y; Lenchik NI; Gerling I; Quarles LD
    Endocrinology; 2012 Oct; 153(10):4608-15. PubMed ID: 22872579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks.
    Pi M; Quarles LD
    Endocrinology; 2012 May; 153(5):2062-9. PubMed ID: 22374969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.
    Pi M; Nishimoto SK; Darryl Quarles L
    Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33474566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPCR6A Is a Molecular Target for the Natural Products Gallate and EGCG in Green Tea.
    Pi M; Kapoor K; Ye R; Smith JC; Baudry J; Quarles LD
    Mol Nutr Food Res; 2018 Apr; 62(8):e1700770. PubMed ID: 29468843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel extracellular cation-sensing G-protein-coupled receptor.
    Pi M; Faber P; Ekema G; Jackson PD; Ting A; Wang N; Fontilla-Poole M; Mays RW; Brunden KR; Harrington JJ; Quarles LD
    J Biol Chem; 2005 Dec; 280(48):40201-9. PubMed ID: 16199532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLK1 Regulates Whole-Body Glucose Metabolism: A Negative Feedback Regulation of the Osteocalcin-Insulin Loop.
    Abdallah BM; Ditzel N; Laborda J; Karsenty G; Kassem M
    Diabetes; 2015 Sep; 64(9):3069-80. PubMed ID: 25918236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of muscle contraction and recombinant osteocalcin on insulin sensitivity ex vivo.
    Levinger I; Lin X; Zhang X; Brennan-Speranza TC; Volpato B; Hayes A; Jerums G; Seeman E; McConell G
    Osteoporos Int; 2016 Feb; 27(2):653-63. PubMed ID: 26259649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a.
    Wei J; Hanna T; Suda N; Karsenty G; Ducy P
    Diabetes; 2014 Mar; 63(3):1021-31. PubMed ID: 24009262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
    Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
    J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired osteoblast function in GPRC6A null mice.
    Pi M; Zhang L; Lei SF; Huang MZ; Zhu W; Zhang J; Shen H; Deng HW; Quarles LD
    J Bone Miner Res; 2010 May; 25(5):1092-102. PubMed ID: 19874200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPRC6A: Jack of all metabolism (or master of none).
    Pi M; Nishimoto SK; Quarles LD
    Mol Metab; 2017 Feb; 6(2):185-193. PubMed ID: 28180060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPRC6A mediates the non-genomic effects of steroids.
    Pi M; Parrill AL; Quarles LD
    J Biol Chem; 2010 Dec; 285(51):39953-64. PubMed ID: 20947496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPRC6A regulates prostate cancer progression.
    Pi M; Quarles LD
    Prostate; 2012 Mar; 72(4):399-409. PubMed ID: 21681779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
    Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
    Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undercarboxylated osteocalcin downregulates pancreatic lipase expression in an ATF4-dependent manner in pancreatic acinar cells.
    Park D; Gu H; Baek JH; Baek K
    Bone; 2019 Oct; 127():220-227. PubMed ID: 31216497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computationally identified novel agonists for GPRC6A.
    Pi M; Kapoor K; Ye R; Hwang DJ; Miller DD; Smith JC; Baudry J; Quarles LD
    PLoS One; 2018; 13(4):e0195980. PubMed ID: 29684031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteocalcin and Sex Hormone Binding Globulin Compete on a Specific Binding Site of GPRC6A.
    De Toni L; Guidolin D; De Filippis V; Tescari S; Strapazzon G; Santa Rocca M; Ferlin A; Plebani M; Foresta C
    Endocrinology; 2016 Nov; 157(11):4473-4486. PubMed ID: 27673554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.